NCI CCC
The Ohio State University Comprehensive Cancer Center


 

 

 

 

 

OSUCCC

Donn C. Young, Ph.D.
Research Scientist
College of Public Health
Center for Biostatistics - Biostatistics
M200 Starling Loving
320 W. 10th Avenue Columbus,OH. 43210

o

(614) 293-3075

f

(614) 293-6902
donn.young@osumc.edu
Programs
 

Current Publications
World J Surg Oncol 7: 34, 2009
Comparison of intraoperative frozen section analysis for sentinel lymph node biopsy during breast cancer surgery for invasive lobular carcinoma and invasive ductal carcinoma.
Horvath JW, Barnett GE, Jimenez RE, Young DC, Povoski SP
Proteomics 9(5): 1197-206, 2009
Validation of an LC-MS based approach for profiling histones in chronic lymphocytic leukemia.
Su X, Lucas DM, Zhang L, Xu H, Zabrouskov V, Davis ME, Knapp AR, Young DC, Payne PR, Parthun MR, Marcucci G, Grever MR, Byrd JC, Freitas MA
Breast Cancer Res Treat 117(1): 83-9, 2008
A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab.
Mani A, Roda J, Young D, Caligiuri MA, Fleming GF, Kaufman P, Brufsky A, Ottman S, Carson WE 3rd, Shapiro CL
J Clin Oncol 25(35): 5624-9, 2008
Computed tomography scans do not improve the predictive power of 1996 national cancer institute sponsored working group chronic lymphocytic leukemia response criteria.
Blum KA, Young DC, Broering S, Lucas MS, Fischer B, Lin TS, Grever MR, Byrd JC
J Neurochem 102(6): 1978-89, 2008
Hippocampal gene expression profiling reveals the possible involvement of Homer1 and GABA(B) receptors in scopolamine-induced amnesia.
Brouillette J, Young DC, During MJ, Quirion R
Ann Oncol 19(8): 1417-22, 2008
Phase II study of sequentially administered low-dose mitomycin-C (MMC) and irinotecan (CPT-11) in women with metastatic breast cancer (MBC).
Mrozek E, Kolesar J, Young DC, Allen J, Villalona-Calero M, Shapiro CL
Cancer 113(12): 3450-8, 2008
Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial.
Andersen BL, Yang HC, Farrar WB, Golden-Kreutz DM, Emery CF, Thornton LM, Young DC, Carson WE 3rd
J Clin Oncol 26(10): 1691-7, 2008
Randomized phase II adjuvant trial of dose-dense docetaxel before or after doxorubicin plus cyclophosphamide in axillary node-positive breast cancer.
Puhalla S, Mrozek E, Young DC, Ottman S, McVey A, Kendra K, Merriman NJ, Knopp M, Patel T, Thompson ME, Maher JF, Moore TD, Shapiro CL
Toxicol Pathol 35(6): 819-26, 2008
Ultraviolet radiation-induced corneal degeneration in 129 mice.
Newkirk KM, Chandler HL, Parent AE, Young DC, Colitz CM, Wilkie DA, Kusewitt DF